1. Home
  2. ANIX vs EVF Comparison

ANIX vs EVF Comparison

Compare ANIX & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.72

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Senior Income Trust

EVF

Eaton Vance Senior Income Trust

HOLD

Current Price

$4.98

Market Cap

90.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
EVF
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
90.3M
IPO Year
2013
1998

Fundamental Metrics

Financial Performance
Metric
ANIX
EVF
Price
$2.72
$4.98
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
94.4K
70.4K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$4.85
52 Week High
$5.46
$5.75

Technical Indicators

Market Signals
Indicator
ANIX
EVF
Relative Strength Index (RSI) 42.94 47.90
Support Level $2.65 $4.92
Resistance Level $3.12 $5.03
Average True Range (ATR) 0.12 0.03
MACD -0.02 0.00
Stochastic Oscillator 28.21 55.56

Price Performance

Historical Comparison
ANIX
EVF

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

Share on Social Networks: